跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,348 条关于
“Partex NV”
全部
2,348
临床试验
1,430
药物
126
机构
91
资讯
701
去年
Fortress Biotech and Partex Form Strategic AI Partnership to Accelerate Drug Discovery and Development
去年
Fortress Biotech Reports Strong 2024 Results with Two FDA Approvals and Strategic Acquisition Deal
2年前
NanoViricides' NV-387 Shows Broad-Spectrum Antiviral Activity Against 'Tripledemic' Viruses and Smallpox in Animal Models
2年前
NanoViricides Develops First-In-Class Broad-Spectrum Antiviral Agent NV-387
去年
NanoViricides' NV-387 Advances to Phase II Clinical Trials for MPox Treatment
去年
NanoViricides Advances NV-387 to Phase II Trials Targeting MPox and Respiratory Infections
去年
NanoViricides Advances NV-387 for Herpes Zoster Treatment to Phase II Trials
去年
NanoViricides' NV-387 Advances to Phase II Trials for Multiple Viral Infections
去年
NanoViricides Advances NV-387 as Potential Treatment for Measles Amid Declining Vaccination Rates
去年
NanoViricides' NV-387 Shows Promise Against H5N1 Bird Flu in Preclinical Studies
第 1 页,共 71 页
上一页
下一页